[Use of 1,2:5,6-dianhydrogalactitol in combination with maytansine in experimental tumor therapy].
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003961:Dianhydrogalactitol / Q000008:administration & dosage*; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D008453:Maytansine / Q000008:administration & dosage*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D010078:Oxazines / Q000008:administration & dosage*; D013402:Sugar Alcohols / Q000008:administration & dosage*
D010078:Oxazines; D013402:Sugar Alcohols; D008453:Maytansine; D003961:Dianhydrogalactitol